These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7859023)

  • 21. Therapeutic implications of lipid-lowering agents in the progression of renal disease.
    Keane WF; Kasiske BL; O'Donnell MP; Schmitz PG
    Am J Med; 1989 Nov; 87(5N):21N-24N. PubMed ID: 2486540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms and treatment of dyslipidemia of renal diseases.
    Toto RD; Vega GL; Grundy SM
    Curr Opin Nephrol Hypertens; 1993 Sep; 2(5):784-90. PubMed ID: 7922219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal lipid metabolism after renal transplantation.
    Wanner C; Quaschning T
    Ann Transplant; 2001; 6(1):5-8. PubMed ID: 11803608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperlipidemia and the progression of renal disease.
    Keane WF; Kasiske BL; O'Donnell MP
    Am J Clin Nutr; 1988 Jan; 47(1):157-60. PubMed ID: 3276133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma lipid alterations in patients with chronic renal disease.
    Cramp DG
    Crit Rev Clin Lab Sci; 1982; 17(1):77-101. PubMed ID: 6749432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid abnormalities in progressive renal insufficiency.
    Attman PO; Samuelsson O; Alaupovic P
    Contrib Nephrol; 1997; 120():1-10. PubMed ID: 9257042
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of dietary manipulation on the lipid abnormalities in patients with chronic renal failure.
    Maschio G; Oldrizzi L; Rugiu C; De Biase V; Loschiavo C
    Kidney Int Suppl; 1991 Apr; 31():S70-2. PubMed ID: 2046274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hyperlipidemia in chronic renal insufficiency].
    Nikiforova NV; Sokolovskaia IV; Ermolenko VM; Tananaeva IK; Zventov VB
    Ter Arkh; 1975; 47(4):76-80. PubMed ID: 1145486
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of the efficiency of treatment of dyslipidaemia in renal outpatients.
    Harris K; Thomas M; Short C; Moore R
    J Nephrol; 2002; 15(3):263-9. PubMed ID: 12113597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Disturbances of lipid metabolism during nephrotic syndrome: physiopathology and treatment].
    Moulin B; Ollier J; Olmer M
    Nephrologie; 1992; 13(5):193-9. PubMed ID: 1470293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease.
    Fried LF
    Kidney Int; 2008 Sep; 74(5):571-6. PubMed ID: 18528321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of reduced renal mass on tissue lipids and renal injury in hyperlipidemic rats.
    Kasiske BL; O'Donnell MP; Cleary MP; Keane WF
    Kidney Int; 1989 Jan; 35(1):40-7. PubMed ID: 2709661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipids and renal disease.
    Trevisan R; Dodesini AR; Lepore G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S145-7. PubMed ID: 16565240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperlipidemia and renal disease: the use of animal models in understanding pathophysiology and approaches to treatment.
    Stevenson FT; Kaysen GA
    Wien Klin Wochenschr; 1999 Apr; 111(8):307-14. PubMed ID: 10378311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory?
    Keane WF; St Peter JV; Kasiske BL
    Kidney Int Suppl; 1992 Oct; 38():S134-41. PubMed ID: 1405364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperlipidemia of chronic renal failure.
    Kaysen GA
    Blood Purif; 1994; 12(1):60-7. PubMed ID: 7986478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipids and progressive renal failure.
    Keane WF
    Wien Klin Wochenschr; 1996; 108(14):420-4. PubMed ID: 8784983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing dyslipidemia in chronic kidney disease.
    Weiner DE; Sarnak MJ
    J Gen Intern Med; 2004 Oct; 19(10):1045-52. PubMed ID: 15482558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glomerular atherosclerosis.
    Moorhead JF; Brunton C; Varghese Z
    Miner Electrolyte Metab; 1997; 23(3-6):287-90. PubMed ID: 9387135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipids and the progression of renal disease.
    Keane WF; O'Donnell MP; Kasiske BL; Schmitz PG
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S69-74. PubMed ID: 16989069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.